Paper19085068
Synergistic effects of miconazole and polymyxin B on microbial pathogens.
Pietschmann S and 3 others. Vet Res Commun, 2009. Cited by 36 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Synergistic effects of miconazole and polymyxin B on microbial pathogens. Papers, record 19085068. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19085068
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Antifungal Agents | Major topic |
| Bacteria | Major topic |
| Malassezia | Major topic |
| Miconazole | Major topic |
| Polymyxin B | Major topic |
| Culture Media | |
| Drug Combinations | |
| Drug Synergism | |
| Escherichia coli | |
| Flow Cytometry | |
| Microbial Sensitivity Tests | |
| Microscopy, Fluorescence | |
| Pseudomonas aeruginosa | |
| Staphylococcus intermedius | |
| Urea |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1406489 | Agents that increase the permeability of the outer membrane. | Microbiol Rev | 1992 | https://conductscience.org/library/papers/1406489 | PubMed |
| 2 | 16954293 | A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole. | J Clin Microbiol | 2006 | https://conductscience.org/library/papers/16954293 | PubMed |
| 3 | 8667037 | In-vitro activity of commonly used antifungal agents in the presence of rifampin, polymyxin B and norfloxacin against Candida albicans. | J Chemother | 1995 | https://conductscience.org/library/papers/8667037 | PubMed |
| 4 | 4303542 | Electron microscopic studies on mode of action of polymyxin. | J Bacteriol | 1969 | https://conductscience.org/library/papers/4303542 | PubMed |
| 5 | 12234832 | Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12234832 | PubMed |
| 6 | 5596142 | Synergy of antibacterial substances by apparently known mechanisms. | Antimicrob Agents Chemother (Bethesda) | 1967 | https://conductscience.org/library/papers/5596142 | PubMed |
| 7 | 167658 | Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/167658 | PubMed |
| 8 | 9065882 | New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa. | J Small Anim Pract | 1997 | https://conductscience.org/library/papers/9065882 | PubMed |
| 10 | 101130 | Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/101130 | PubMed |
| 11 | 16238809 | A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa. | Vet Dermatol | 2005 | https://conductscience.org/library/papers/16238809 | PubMed |
| 12 | 2580220 | Molecular basis of bacterial outer membrane permeability. | Microbiol Rev | 1985 | https://conductscience.org/library/papers/2580220 | PubMed |
| 13 | 202585 | Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B. | J Antibiot (Tokyo) | 1977 | https://conductscience.org/library/papers/202585 | PubMed |
| 15 | 12489709 | Identification and antimicrobial susceptibility of coagulase positive staphylococci isolated from healthy dogs and dogs suffering from otitis externa. | J Vet Med B Infect Dis Vet Public Health | 2002 | https://conductscience.org/library/papers/12489709 | PubMed |
| 16 | 6317296 | Synergism of the antimicrobial agents miconazole, bacitracin and polymyxin B. | Chemotherapy | 1983 | https://conductscience.org/library/papers/6317296 | PubMed |
| 17 | 16086654 | Update on antimicrobial agents: new indications of older agents. | Expert Opin Pharmacother | 2005 | https://conductscience.org/library/papers/16086654 | PubMed |
| 18 | 15825399 | Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15825399 | PubMed |
| 19 | 6093683 | Alterations in outer membrane permeability. | Annu Rev Microbiol | 1984 | https://conductscience.org/library/papers/6093683 | PubMed |
| 20 | 1888310 | A clinical trial of a topical preparation of miconazole, polymyxin and prednisolone in the treatment of otitis externa in dogs. | Aust Vet J | 1991 | https://conductscience.org/library/papers/1888310 | PubMed |
| 21 | 12805255 | Synergy, antagonism, and what the chequerboard puts between them. | J Antimicrob Chemother | 2003 | https://conductscience.org/library/papers/12805255 | PubMed |
| 22 | 7115614 | Synergism of the antimicrobial agents miconazole and benzoylperoxide. | Br J Dermatol | 1982 | https://conductscience.org/library/papers/7115614 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38724627 | Miconazole and phenothiazine hinder the quorum sensing regulated virulence in Pseudomonas aeruginosa. | J Antibiot (Tokyo) | 2024 | https://conductscience.org/library/papers/38724627 | PubMed |
| 36558754 | Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations. | Pathogens | 2022 | https://conductscience.org/library/papers/36558754 | PubMed |
| 35467374 | Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35467374 | PubMed |
| 34769486 | Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769486 | PubMed |
| 33821795 | Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. | Elife | 2021 | https://conductscience.org/library/papers/33821795 | PubMed |
| 32984281 | Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/32984281 | PubMed |
| 29706941 | Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29706941 | PubMed |
| 29371554 | Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis. | J Fungi (Basel) | 2017 | https://conductscience.org/library/papers/29371554 | PubMed |
| 28248999 | Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models. | PLoS One | 2017 | https://conductscience.org/library/papers/28248999 | PubMed |
| 26138434 | Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium. | Mycopathologia | 2015 | https://conductscience.org/library/papers/26138434 | PubMed |
| 25050379 | Development and characterization of polyphenon 60 and caffeine microemulsion for enhanced antibacterial activity. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25050379 | PubMed |
| 24629000 | The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide. | BMC Microbiol | 2014 | https://conductscience.org/library/papers/24629000 | PubMed |
| 24069959 | The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. | BMC Microbiol | 2013 | https://conductscience.org/library/papers/24069959 | PubMed |
| 23721182 | The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries. | Vet Dermatol | 2013 | https://conductscience.org/library/papers/23721182 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19085068
GET https://conductscience.org/api/papers/v1/19085068/references?page=2